nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—IL3—blood plasma—systemic lupus erythematosus	0.0462	0.149	CbGeAlD
Amlexanox—IL3—connective tissue—systemic lupus erythematosus	0.0246	0.0795	CbGeAlD
Amlexanox—IL3—lymphoid tissue—systemic lupus erythematosus	0.018	0.0581	CbGeAlD
Amlexanox—IL3—bone marrow—systemic lupus erythematosus	0.0164	0.0529	CbGeAlD
Amlexanox—FGF1—endothelium—systemic lupus erythematosus	0.0152	0.0491	CbGeAlD
Amlexanox—FGF1—blood plasma—systemic lupus erythematosus	0.0135	0.0436	CbGeAlD
Amlexanox—S100A13—connective tissue—systemic lupus erythematosus	0.0117	0.0377	CbGeAlD
Amlexanox—S100A12—connective tissue—systemic lupus erythematosus	0.0115	0.0372	CbGeAlD
Amlexanox—S100A13—skin of body—systemic lupus erythematosus	0.0105	0.0341	CbGeAlD
Amlexanox—S100A12—lymphoid tissue—systemic lupus erythematosus	0.00842	0.0272	CbGeAlD
Amlexanox—S100A12—bone marrow—systemic lupus erythematosus	0.00766	0.0248	CbGeAlD
Amlexanox—FGF1—connective tissue—systemic lupus erythematosus	0.00718	0.0232	CbGeAlD
Amlexanox—S100A13—lung—systemic lupus erythematosus	0.00704	0.0228	CbGeAlD
Amlexanox—FGF1—nephron tubule—systemic lupus erythematosus	0.00696	0.0225	CbGeAlD
Amlexanox—S100A12—lung—systemic lupus erythematosus	0.00694	0.0225	CbGeAlD
Amlexanox—S100A13—nervous system—systemic lupus erythematosus	0.00652	0.0211	CbGeAlD
Amlexanox—FGF1—skin of body—systemic lupus erythematosus	0.00649	0.021	CbGeAlD
Amlexanox—PDE4D—cortex of kidney—systemic lupus erythematosus	0.00637	0.0206	CbGeAlD
Amlexanox—S100A13—central nervous system—systemic lupus erythematosus	0.00627	0.0203	CbGeAlD
Amlexanox—FGF1—kidney—systemic lupus erythematosus	0.00611	0.0198	CbGeAlD
Amlexanox—FGF1—cortex of kidney—systemic lupus erythematosus	0.00596	0.0193	CbGeAlD
Amlexanox—Aphthous stomatitis—Leflunomide—systemic lupus erythematosus	0.00583	0.0817	CcSEcCtD
Amlexanox—PDE4D—tendon—systemic lupus erythematosus	0.00528	0.0171	CbGeAlD
Amlexanox—FGF1—lymphoid tissue—systemic lupus erythematosus	0.00525	0.017	CbGeAlD
Amlexanox—PDE4C—nervous system—systemic lupus erythematosus	0.00487	0.0158	CbGeAlD
Amlexanox—PDE4C—central nervous system—systemic lupus erythematosus	0.00469	0.0152	CbGeAlD
Amlexanox—PDE4D—lung—systemic lupus erythematosus	0.00463	0.015	CbGeAlD
Amlexanox—FGF1—lung—systemic lupus erythematosus	0.00433	0.014	CbGeAlD
Amlexanox—PDE4A—lung—systemic lupus erythematosus	0.0041	0.0133	CbGeAlD
Amlexanox—FGF1—nervous system—systemic lupus erythematosus	0.00401	0.013	CbGeAlD
Amlexanox—FGF1—central nervous system—systemic lupus erythematosus	0.00386	0.0125	CbGeAlD
Amlexanox—Throat sore—Leflunomide—systemic lupus erythematosus	0.0038	0.0532	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Leflunomide—systemic lupus erythematosus	0.00376	0.0527	CcSEcCtD
Amlexanox—PDE4B—cortex of kidney—systemic lupus erythematosus	0.00336	0.0109	CbGeAlD
Amlexanox—Oropharyngeal pain—Leflunomide—systemic lupus erythematosus	0.00301	0.0421	CcSEcCtD
Amlexanox—PDE4B—lymphoid tissue—systemic lupus erythematosus	0.00296	0.00958	CbGeAlD
Amlexanox—PDE4B—tendon—systemic lupus erythematosus	0.00278	0.00901	CbGeAlD
Amlexanox—PDE4B—bone marrow—systemic lupus erythematosus	0.0027	0.00873	CbGeAlD
Amlexanox—Mouth ulceration—Leflunomide—systemic lupus erythematosus	0.00247	0.0346	CcSEcCtD
Amlexanox—Throat sore—Triamcinolone—systemic lupus erythematosus	0.00245	0.0343	CcSEcCtD
Amlexanox—PDE4B—lung—systemic lupus erythematosus	0.00244	0.00791	CbGeAlD
Amlexanox—Oropharyngeal discomfort—Triamcinolone—systemic lupus erythematosus	0.00243	0.034	CcSEcCtD
Amlexanox—PDE4B—nervous system—systemic lupus erythematosus	0.00226	0.00732	CbGeAlD
Amlexanox—PDE4B—central nervous system—systemic lupus erythematosus	0.00218	0.00705	CbGeAlD
Amlexanox—Oropharyngeal pain—Triamcinolone—systemic lupus erythematosus	0.00194	0.0272	CcSEcCtD
Amlexanox—Mouth ulceration—Mycophenolate mofetil—systemic lupus erythematosus	0.00186	0.0261	CcSEcCtD
Amlexanox—Liver function test abnormal—Leflunomide—systemic lupus erythematosus	0.00183	0.0257	CcSEcCtD
Amlexanox—Stomatitis—Leflunomide—systemic lupus erythematosus	0.00149	0.0209	CcSEcCtD
Amlexanox—Liver function test abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.00138	0.0193	CcSEcCtD
Amlexanox—Stomatitis—Cyclosporine—systemic lupus erythematosus	0.00115	0.0161	CcSEcCtD
Amlexanox—Headache—Dapsone—systemic lupus erythematosus	0.00115	0.016	CcSEcCtD
Amlexanox—Stomatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.00112	0.0157	CcSEcCtD
Amlexanox—Nausea—Dapsone—systemic lupus erythematosus	0.00109	0.0152	CcSEcCtD
Amlexanox—Mouth ulceration—Methotrexate—systemic lupus erythematosus	0.00105	0.0148	CcSEcCtD
Amlexanox—Nervous system disorder—Leflunomide—systemic lupus erythematosus	0.000957	0.0134	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.000892	0.0125	CcSEcCtD
Amlexanox—Paraesthesia—Leflunomide—systemic lupus erythematosus	0.000876	0.0123	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.000843	0.0118	CcSEcCtD
Amlexanox—Pain—Leflunomide—systemic lupus erythematosus	0.000835	0.0117	CcSEcCtD
Amlexanox—Liver function test abnormal—Methotrexate—systemic lupus erythematosus	0.000782	0.011	CcSEcCtD
Amlexanox—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.000739	0.0103	CcSEcCtD
Amlexanox—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000721	0.0101	CcSEcCtD
Amlexanox—Paraesthesia—Cyclosporine—systemic lupus erythematosus	0.000676	0.00947	CcSEcCtD
Amlexanox—Paraesthesia—Mycophenolate mofetil—systemic lupus erythematosus	0.00066	0.00924	CcSEcCtD
Amlexanox—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000657	0.00919	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.00065	0.00911	CcSEcCtD
Amlexanox—Headache—Azathioprine—systemic lupus erythematosus	0.000647	0.00907	CcSEcCtD
Amlexanox—Pain—Cyclosporine—systemic lupus erythematosus	0.000644	0.00902	CcSEcCtD
Amlexanox—Stomatitis—Methotrexate—systemic lupus erythematosus	0.000636	0.00891	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000634	0.00888	CcSEcCtD
Amlexanox—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000628	0.0088	CcSEcCtD
Amlexanox—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000617	0.00864	CcSEcCtD
Amlexanox—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.000615	0.00862	CcSEcCtD
Amlexanox—Nausea—Azathioprine—systemic lupus erythematosus	0.000614	0.0086	CcSEcCtD
Amlexanox—Headache—Leflunomide—systemic lupus erythematosus	0.000611	0.00856	CcSEcCtD
Amlexanox—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000601	0.00842	CcSEcCtD
Amlexanox—Pain—Prednisolone—systemic lupus erythematosus	0.000586	0.00821	CcSEcCtD
Amlexanox—Nausea—Leflunomide—systemic lupus erythematosus	0.00058	0.00812	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000578	0.00809	CcSEcCtD
Amlexanox—Pain—Hydrocortisone—systemic lupus erythematosus	0.000572	0.00802	CcSEcCtD
Amlexanox—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000566	0.00793	CcSEcCtD
Amlexanox—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000565	0.00791	CcSEcCtD
Amlexanox—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000561	0.00785	CcSEcCtD
Amlexanox—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000561	0.00785	CcSEcCtD
Amlexanox—Pain—Triamcinolone—systemic lupus erythematosus	0.000539	0.00755	CcSEcCtD
Amlexanox—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000514	0.00719	CcSEcCtD
Amlexanox—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000514	0.00719	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000494	0.00692	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000494	0.00692	CcSEcCtD
Amlexanox—Pain—Dexamethasone—systemic lupus erythematosus	0.000489	0.00685	CcSEcCtD
Amlexanox—Pain—Betamethasone—systemic lupus erythematosus	0.000489	0.00685	CcSEcCtD
Amlexanox—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000488	0.00684	CcSEcCtD
Amlexanox—Headache—Cyclosporine—systemic lupus erythematosus	0.000472	0.00661	CcSEcCtD
Amlexanox—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.00046	0.00645	CcSEcCtD
Amlexanox—Nausea—Cyclosporine—systemic lupus erythematosus	0.000447	0.00627	CcSEcCtD
Amlexanox—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000447	0.00626	CcSEcCtD
Amlexanox—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000436	0.00611	CcSEcCtD
Amlexanox—Headache—Prednisolone—systemic lupus erythematosus	0.000429	0.00601	CcSEcCtD
Amlexanox—Headache—Hydrocortisone—systemic lupus erythematosus	0.000419	0.00587	CcSEcCtD
Amlexanox—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000408	0.00572	CcSEcCtD
Amlexanox—Nausea—Prednisolone—systemic lupus erythematosus	0.000407	0.0057	CcSEcCtD
Amlexanox—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000398	0.00557	CcSEcCtD
Amlexanox—Headache—Triamcinolone—systemic lupus erythematosus	0.000395	0.00553	CcSEcCtD
Amlexanox—Headache—Methylprednisolone—systemic lupus erythematosus	0.000394	0.00552	CcSEcCtD
Amlexanox—Nausea—Triamcinolone—systemic lupus erythematosus	0.000374	0.00524	CcSEcCtD
Amlexanox—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.000374	0.00523	CcSEcCtD
Amlexanox—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000374	0.00523	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000359	0.00503	CcSEcCtD
Amlexanox—Headache—Dexamethasone—systemic lupus erythematosus	0.000358	0.00502	CcSEcCtD
Amlexanox—Headache—Betamethasone—systemic lupus erythematosus	0.000358	0.00502	CcSEcCtD
Amlexanox—Pain—Methotrexate—systemic lupus erythematosus	0.000356	0.00499	CcSEcCtD
Amlexanox—Nausea—Betamethasone—systemic lupus erythematosus	0.00034	0.00476	CcSEcCtD
Amlexanox—Nausea—Dexamethasone—systemic lupus erythematosus	0.00034	0.00476	CcSEcCtD
Amlexanox—Headache—Prednisone—systemic lupus erythematosus	0.000312	0.00437	CcSEcCtD
Amlexanox—Nausea—Prednisone—systemic lupus erythematosus	0.000296	0.00414	CcSEcCtD
Amlexanox—Headache—Methotrexate—systemic lupus erythematosus	0.000261	0.00365	CcSEcCtD
Amlexanox—Nausea—Methotrexate—systemic lupus erythematosus	0.000247	0.00346	CcSEcCtD
Amlexanox—IL3—Immune System—IFNG—systemic lupus erythematosus	0.000121	0.000196	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CD80—systemic lupus erythematosus	0.000121	0.000195	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CCR5—systemic lupus erythematosus	0.000121	0.000195	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.00012	0.000194	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.00012	0.000193	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.00012	0.000193	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IFNA1—systemic lupus erythematosus	0.000119	0.000193	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.000119	0.000193	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL2RA—systemic lupus erythematosus	0.000119	0.000192	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CSK—systemic lupus erythematosus	0.000118	0.000191	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—IL2—systemic lupus erythematosus	0.000118	0.00019	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—C3—systemic lupus erythematosus	0.000118	0.00019	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.000118	0.00019	CbGpPWpGaD
Amlexanox—IL3—Immune System—CD4—systemic lupus erythematosus	0.000117	0.000189	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NCF2—systemic lupus erythematosus	0.000117	0.000189	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—C3—systemic lupus erythematosus	0.000117	0.000188	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.000117	0.000188	CbGpPWpGaD
Amlexanox—FGF1—Immune System—RASGRP1—systemic lupus erythematosus	0.000116	0.000188	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—LYN—systemic lupus erythematosus	0.000116	0.000187	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD79A—systemic lupus erythematosus	0.000116	0.000187	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD80—systemic lupus erythematosus	0.000116	0.000187	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.000114	0.000185	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.000114	0.000184	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.000114	0.000184	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—IL6—systemic lupus erythematosus	0.000114	0.000183	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000113	0.000183	CbGpPWpGaD
Amlexanox—FGF1—Disease—JUNB—systemic lupus erythematosus	0.000113	0.000182	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000113	0.000182	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PRL—systemic lupus erythematosus	0.000113	0.000182	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—F2—systemic lupus erythematosus	0.000112	0.000181	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.000112	0.000181	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—C3—systemic lupus erythematosus	0.000111	0.00018	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—JUNB—systemic lupus erythematosus	0.000111	0.000179	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.00011	0.000178	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CSK—systemic lupus erythematosus	0.00011	0.000178	CbGpPWpGaD
Amlexanox—IL3—Immune System—CDKN1B—systemic lupus erythematosus	0.00011	0.000178	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.000109	0.000176	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.000108	0.000175	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NCF2—systemic lupus erythematosus	0.000108	0.000175	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—C3—systemic lupus erythematosus	0.000108	0.000174	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL2—systemic lupus erythematosus	0.000108	0.000174	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—F2—systemic lupus erythematosus	0.000108	0.000174	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—LYN—systemic lupus erythematosus	0.000107	0.000173	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HLA-DQA1—systemic lupus erythematosus	0.000107	0.000173	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.000107	0.000172	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—C3—systemic lupus erythematosus	0.000106	0.000171	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.000106	0.000171	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.000105	0.00017	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.000105	0.00017	CbGpPWpGaD
Amlexanox—FGF1—Disease—PRL—systemic lupus erythematosus	0.000104	0.000168	CbGpPWpGaD
Amlexanox—S100A12—Immune System—TYK2—systemic lupus erythematosus	0.000104	0.000168	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—F2—systemic lupus erythematosus	0.000104	0.000167	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—F2—systemic lupus erythematosus	0.000102	0.000165	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PRL—systemic lupus erythematosus	0.000102	0.000165	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—TYK2—systemic lupus erythematosus	0.000102	0.000164	CbGpPWpGaD
Amlexanox—IL3—Immune System—CDKN1A—systemic lupus erythematosus	0.000102	0.000164	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NCF2—systemic lupus erythematosus	0.000101	0.000163	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.0001	0.000162	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—LYN—systemic lupus erythematosus	0.0001	0.000162	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HLA-DQB1—systemic lupus erythematosus	0.0001	0.000162	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.0001	0.000162	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CD80—systemic lupus erythematosus	9.92e-05	0.00016	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL2RA—systemic lupus erythematosus	9.89e-05	0.00016	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SH2B3—systemic lupus erythematosus	9.83e-05	0.000159	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CXCL12—systemic lupus erythematosus	9.82e-05	0.000158	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—C3—systemic lupus erythematosus	9.8e-05	0.000158	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—F2—systemic lupus erythematosus	9.77e-05	0.000158	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IFNG—systemic lupus erythematosus	9.72e-05	0.000157	CbGpPWpGaD
Amlexanox—IL3—Immune System—EP300—systemic lupus erythematosus	9.67e-05	0.000156	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—JUNB—systemic lupus erythematosus	9.64e-05	0.000156	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL18—systemic lupus erythematosus	9.49e-05	0.000153	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—F2—systemic lupus erythematosus	9.48e-05	0.000153	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD40LG—systemic lupus erythematosus	9.45e-05	0.000153	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CD4—systemic lupus erythematosus	9.39e-05	0.000152	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CXCL12—systemic lupus erythematosus	9.34e-05	0.000151	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD8A—systemic lupus erythematosus	9.34e-05	0.000151	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—F2—systemic lupus erythematosus	9.3e-05	0.00015	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CCL2—systemic lupus erythematosus	9.23e-05	0.000149	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CD4—systemic lupus erythematosus	9.21e-05	0.000149	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—JUNB—systemic lupus erythematosus	9.17e-05	0.000148	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RASGRP1—systemic lupus erythematosus	9.16e-05	0.000148	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—TYK2—systemic lupus erythematosus	9.09e-05	0.000147	CbGpPWpGaD
Amlexanox—FGF1—Immune System—JAK1—systemic lupus erythematosus	9.02e-05	0.000146	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PRL—systemic lupus erythematosus	8.88e-05	0.000143	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD4—systemic lupus erythematosus	8.85e-05	0.000143	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CDKN1B—systemic lupus erythematosus	8.83e-05	0.000143	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—IL6—systemic lupus erythematosus	8.74e-05	0.000141	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—IL6—systemic lupus erythematosus	8.72e-05	0.000141	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.71e-05	0.000141	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CCL2—systemic lupus erythematosus	8.71e-05	0.000141	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CDKN1B—systemic lupus erythematosus	8.66e-05	0.00014	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CXCL12—systemic lupus erythematosus	8.65e-05	0.00014	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL2—systemic lupus erythematosus	8.64e-05	0.000139	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—F2—systemic lupus erythematosus	8.61e-05	0.000139	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—JUNB—systemic lupus erythematosus	8.49e-05	0.000137	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PRL—systemic lupus erythematosus	8.45e-05	0.000136	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL2RA—systemic lupus erythematosus	8.42e-05	0.000136	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TYK2—systemic lupus erythematosus	8.38e-05	0.000135	CbGpPWpGaD
Amlexanox—FGF1—Immune System—C3—systemic lupus erythematosus	8.35e-05	0.000135	CbGpPWpGaD
Amlexanox—FGF1—Disease—JAK1—systemic lupus erythematosus	8.33e-05	0.000134	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—IL2—systemic lupus erythematosus	8.32e-05	0.000134	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CDKN1B—systemic lupus erythematosus	8.32e-05	0.000134	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CCL2—systemic lupus erythematosus	8.29e-05	0.000134	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NOS3—systemic lupus erythematosus	8.22e-05	0.000133	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—JAK1—systemic lupus erythematosus	8.16e-05	0.000132	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CDKN1A—systemic lupus erythematosus	8.15e-05	0.000132	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.06e-05	0.00013	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CXCL12—systemic lupus erythematosus	8.06e-05	0.00013	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CDKN1A—systemic lupus erythematosus	7.99e-05	0.000129	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CRP—systemic lupus erythematosus	7.95e-05	0.000128	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—JUNB—systemic lupus erythematosus	7.91e-05	0.000128	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—TYK2—systemic lupus erythematosus	7.91e-05	0.000128	CbGpPWpGaD
Amlexanox—FGF1—Disease—CCR5—systemic lupus erythematosus	7.89e-05	0.000127	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PRL—systemic lupus erythematosus	7.82e-05	0.000126	CbGpPWpGaD
Amlexanox—S100A12—Immune System—EP300—systemic lupus erythematosus	7.75e-05	0.000125	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCR5—systemic lupus erythematosus	7.73e-05	0.000125	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CDKN1A—systemic lupus erythematosus	7.68e-05	0.000124	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CCL2—systemic lupus erythematosus	7.67e-05	0.000124	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL2RA—systemic lupus erythematosus	7.62e-05	0.000123	CbGpPWpGaD
Amlexanox—FGF1—Immune System—TLR4—systemic lupus erythematosus	7.62e-05	0.000123	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HLA-DRB1—systemic lupus erythematosus	7.61e-05	0.000123	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—EP300—systemic lupus erythematosus	7.61e-05	0.000123	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL2—systemic lupus erythematosus	7.56e-05	0.000122	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—C3—systemic lupus erythematosus	7.55e-05	0.000122	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—TYK2—systemic lupus erythematosus	7.53e-05	0.000122	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	7.52e-05	0.000121	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PRL—systemic lupus erythematosus	7.29e-05	0.000118	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—IL2—systemic lupus erythematosus	7.25e-05	0.000117	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.12e-05	0.000115	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—JAK1—systemic lupus erythematosus	7.1e-05	0.000115	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD80—systemic lupus erythematosus	7.03e-05	0.000113	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL2—systemic lupus erythematosus	6.97e-05	0.000113	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—TYK2—systemic lupus erythematosus	6.97e-05	0.000112	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—IL6—systemic lupus erythematosus	6.94e-05	0.000112	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—IL2—systemic lupus erythematosus	6.9e-05	0.000111	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—JAK1—systemic lupus erythematosus	6.76e-05	0.000109	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCR5—systemic lupus erythematosus	6.73e-05	0.000109	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—F2—systemic lupus erythematosus	6.63e-05	0.000107	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.63e-05	0.000107	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MMP9—systemic lupus erythematosus	6.6e-05	0.000106	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL2—systemic lupus erythematosus	6.58e-05	0.000106	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—C3—systemic lupus erythematosus	6.58e-05	0.000106	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.57e-05	0.000106	CbGpPWpGaD
Amlexanox—FGF1—Disease—CD80—systemic lupus erythematosus	6.49e-05	0.000105	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCR5—systemic lupus erythematosus	6.4e-05	0.000103	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—IL2—systemic lupus erythematosus	6.38e-05	0.000103	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CD80—systemic lupus erythematosus	6.36e-05	0.000103	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL6—systemic lupus erythematosus	6.34e-05	0.000102	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.31e-05	0.000102	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL2—systemic lupus erythematosus	6.26e-05	0.000101	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—C3—systemic lupus erythematosus	6.26e-05	0.000101	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—EP300—systemic lupus erythematosus	6.25e-05	0.000101	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—JAK1—systemic lupus erythematosus	6.25e-05	0.000101	CbGpPWpGaD
Amlexanox—FGF1—Immune System—TYK2—systemic lupus erythematosus	5.93e-05	9.58e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCR5—systemic lupus erythematosus	5.93e-05	9.57e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.92e-05	9.56e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCL2—systemic lupus erythematosus	5.91e-05	9.54e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.84e-05	9.43e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—JAK1—systemic lupus erythematosus	5.83e-05	9.41e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL2—systemic lupus erythematosus	5.8e-05	9.36e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—C3—systemic lupus erythematosus	5.79e-05	9.35e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—F2—systemic lupus erythematosus	5.77e-05	9.32e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IFNG—systemic lupus erythematosus	5.56e-05	8.97e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CD80—systemic lupus erythematosus	5.53e-05	8.93e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCR5—systemic lupus erythematosus	5.53e-05	8.92e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—F2—systemic lupus erythematosus	5.49e-05	8.87e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—TYK2—systemic lupus erythematosus	5.48e-05	8.84e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.45e-05	8.79e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.44e-05	8.78e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—C3—systemic lupus erythematosus	5.4e-05	8.72e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—NOS3—systemic lupus erythematosus	5.38e-05	8.68e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TYK2—systemic lupus erythematosus	5.37e-05	8.66e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD4—systemic lupus erythematosus	5.37e-05	8.66e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CD80—systemic lupus erythematosus	5.27e-05	8.5e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NOS3—systemic lupus erythematosus	5.27e-05	8.5e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCL2—systemic lupus erythematosus	5.15e-05	8.31e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—F2—systemic lupus erythematosus	5.08e-05	8.21e-05	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL6—systemic lupus erythematosus	5.08e-05	8.2e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CDKN1B—systemic lupus erythematosus	5.05e-05	8.15e-05	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IL6—systemic lupus erythematosus	4.98e-05	8.04e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—CD4—systemic lupus erythematosus	4.95e-05	8e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL2—systemic lupus erythematosus	4.94e-05	7.97e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTGS2—systemic lupus erythematosus	4.92e-05	7.94e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCL2—systemic lupus erythematosus	4.9e-05	7.91e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CD80—systemic lupus erythematosus	4.87e-05	7.87e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—F2—systemic lupus erythematosus	4.74e-05	7.65e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TYK2—systemic lupus erythematosus	4.67e-05	7.54e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—CDKN1B—systemic lupus erythematosus	4.66e-05	7.52e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CDKN1A—systemic lupus erythematosus	4.66e-05	7.52e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NOS3—systemic lupus erythematosus	4.59e-05	7.4e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.56e-05	7.37e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CD80—systemic lupus erythematosus	4.54e-05	7.34e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCL2—systemic lupus erythematosus	4.53e-05	7.32e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL2—systemic lupus erythematosus	4.47e-05	7.21e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TYK2—systemic lupus erythematosus	4.45e-05	7.18e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL6—systemic lupus erythematosus	4.44e-05	7.17e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—EP300—systemic lupus erythematosus	4.43e-05	7.15e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NOS3—systemic lupus erythematosus	4.37e-05	7.05e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—CDKN1A—systemic lupus erythematosus	4.3e-05	6.94e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MMP9—systemic lupus erythematosus	4.23e-05	6.82e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCL2—systemic lupus erythematosus	4.23e-05	6.82e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.21e-05	6.8e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TYK2—systemic lupus erythematosus	4.11e-05	6.64e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL6—systemic lupus erythematosus	4.1e-05	6.61e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—EP300—systemic lupus erythematosus	4.09e-05	6.6e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NOS3—systemic lupus erythematosus	4.04e-05	6.52e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—EP300—systemic lupus erythematosus	4.01e-05	6.47e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.97e-05	6.41e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL2—systemic lupus erythematosus	3.89e-05	6.28e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL6—systemic lupus erythematosus	3.87e-05	6.24e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TYK2—systemic lupus erythematosus	3.84e-05	6.19e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.8e-05	6.13e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.78e-05	6.1e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NOS3—systemic lupus erythematosus	3.77e-05	6.08e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL2—systemic lupus erythematosus	3.7e-05	5.97e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL6—systemic lupus erythematosus	3.68e-05	5.94e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MMP9—systemic lupus erythematosus	3.68e-05	5.94e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.67e-05	5.92e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—TGFB1—systemic lupus erythematosus	3.56e-05	5.74e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MMP9—systemic lupus erythematosus	3.5e-05	5.65e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.5e-05	5.65e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.49e-05	5.63e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—EP300—systemic lupus erythematosus	3.49e-05	5.63e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.48e-05	5.62e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL2—systemic lupus erythematosus	3.42e-05	5.53e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL6—systemic lupus erythematosus	3.41e-05	5.5e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—EP300—systemic lupus erythematosus	3.32e-05	5.36e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.3e-05	5.33e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.26e-05	5.27e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MMP9—systemic lupus erythematosus	3.24e-05	5.23e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.23e-05	5.21e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL2—systemic lupus erythematosus	3.19e-05	5.15e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.14e-05	5.08e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—EP300—systemic lupus erythematosus	3.07e-05	4.96e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.03e-05	4.9e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MMP9—systemic lupus erythematosus	3.02e-05	4.88e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.01e-05	4.86e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.91e-05	4.7e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL6—systemic lupus erythematosus	2.9e-05	4.69e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.89e-05	4.66e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—EP300—systemic lupus erythematosus	2.86e-05	4.62e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.71e-05	4.38e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—IL6—systemic lupus erythematosus	2.68e-05	4.33e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.67e-05	4.31e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6—systemic lupus erythematosus	2.62e-05	4.24e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.49e-05	4.02e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6—systemic lupus erythematosus	2.29e-05	3.69e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6—systemic lupus erythematosus	2.18e-05	3.51e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6—systemic lupus erythematosus	2.01e-05	3.25e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6—systemic lupus erythematosus	1.88e-05	3.03e-05	CbGpPWpGaD
